Stago is a global in vitro diagnostics (IVD) company founded in 1945 and now operating as a worldwide reference in haemostasis and thrombosis testing. The company maintains end-to-end control of its business across research and development, manufacturing, logistics, marketing, sales, and international distribution, with its primary reagent manufact... uring plant certified to ISO 13485, ISO 9001, and ISO 14001 standards. Stago's industrial operations are concentrated in France, where the majority of its nearly 2,600 employees are based, while the company has expanded its geographic footprint through the establishment of dedicated R&D and production centers in the United States, Netherlands, Germany, Ireland, and China. Since establishing its American subsidiary in 1985, Stago has grown its distribution network substantially, opening 17 new affiliates across key markets including the United Kingdom, United Arab Emirates, Australia, New Zealand, Canada, Hong Kong, Austria, Spain, Italy, Portugal, Switzerland, Belgium, India, Brazil, and Turkey. The company markets over 350 products and serves biomedical laboratories worldwide with a comprehensive range of haemostasis test instruments and reagents developed using advanced technologies. Stago's commitment to customer satisfaction and patient-centric operations is embedded throughout the organization, supported by a licensed training center that delivers theoretical and practical courses at multiple levels to laboratory professionals specializing in haemostasis and thrombosis. The company's diverse workforce and multidisciplinary expertise enable continuous investment in research and innovation, positioning Stago as a first-class partner for clinical laboratories seeking reliable, comprehensive solutions in coagulation and thrombosis diagnostics.Read More